Efficiency of CYP2C9 Genetic Test Representation for Automated Pharmacogenetic Decision Support
暂无分享,去创建一个
Bruce E Bray | Vikrant G Deshmukh | Mark A Hoffman | Catherine Arnoldi | Joyce A Mitchell | B. Bray | C. Arnoldi | M. A. Hoffman | J. Mitchell | V. G. Deshmukh
[1] L. Kaminsky,et al. Human P450 metabolism of warfarin. , 1997, Pharmacology & therapeutics.
[2] Magnus Ingelman-Sundberg,et al. CYPalleles: a web page for nomenclature of human cytochrome P450 alleles. , 2002, Drug metabolism and pharmacokinetics.
[3] Joyce A. Mitchell,et al. Status of clinical gene sequencing data reporting and associated risks for information loss , 2007, J. Biomed. Informatics.
[4] V. Maojo,et al. Integrating Genomics into Health Information Systems , 2002, Methods of Information in Medicine.
[5] L. Wienkers,et al. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. , 1994, Pharmacogenetics.
[6] J D Horton,et al. Warfarin therapy: evolving strategies in anticoagulation. , 1999, American family physician.
[7] G. Aithal,et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications , 1999, The Lancet.
[8] R. Altman,et al. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base. , 2005, Methods in molecular biology.
[9] H Furuya,et al. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy. , 1995, Pharmacogenetics.
[10] R G Bell,et al. Mechanism of action of warfarin. Warfarin and metabolism of vitamin K 1 . , 1972, Biochemistry.
[11] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[12] M. Hoffman,et al. The Clinical Bioinformatics Ontology: A Curated Semantic Network Utilizing RefSeq Information , 2004, Pacific Symposium on Biocomputing.
[13] Amnon Shabo,et al. The seventh layer of the clinical-genomics information infrastructure , 2007, IBM Syst. J..
[14] A T McCray,et al. From Phenotype to Genotype: Issues in Navigating the Available Information Resources , 2003, Methods of Information in Medicine.
[15] F. Collins,et al. A vision for the future of genomics research , 2003, Nature.
[16] C. McDonald,et al. LOINC, a universal standard for identifying laboratory observations: a 5-year update. , 2003, Clinical chemistry.
[17] M H Tarbit,et al. Genetic analysis of the human cytochrome P450 CYP2C9 locus. , 1996, Pharmacogenetics.
[18] J. Bonfield,et al. Finishing the euchromatic sequence of the human genome , 2004, Nature.
[19] Peter Wood,et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. , 2005, Blood.
[20] Andreas Fregin,et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 , 2004, Nature.
[21] F. Collins,et al. Welcome to the genomic era. , 2003, The New England journal of medicine.
[22] H. Echizen,et al. Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin , 2003, The Pharmacogenomics Journal.
[23] Joyce A. Mitchell,et al. The impact of genomics on E-health. , 2004, Studies in health technology and informatics.